Contemporary Multidisciplinary Management of Sinonasal Mucosal Melanoma
- PMID: 32214828
- PMCID: PMC7083634
- DOI: 10.2147/OTT.S182580
Contemporary Multidisciplinary Management of Sinonasal Mucosal Melanoma
Abstract
Sinonasal mucosal melanoma (SNMM) is a rare tumor, comprising less than 10% of sinonasal malignancies. SNMM most frequently occurs in the nasal cavity (70%) and maxillary sinus (14%), typically as black patches. Overall, SNMM harbors a very poor prognosis; 5-year survival is less than 30%. Nasal cavity tumors confer a better prognosis than sinus melanoma. The primary management for SNMM is surgery, when feasible, followed by adjuvant radiotherapy. Recent studies suggest that immunotherapy may confer survival benefit to patients with advanced disease. The multidisciplinary team approach has been shown to optimize treatment, reduce costs, and minimize adverse events, while maximizing the chances for cure.
Keywords: head and neck; mucosal melanoma; multidisciplinary.
© 2020 Na’ara et al.
Conflict of interest statement
The authors report no conflicts of interest in this work.
Figures
References
Publication types
LinkOut - more resources
Full Text Sources